|
Mar 12
|
Result of Extraordinary General Meeting and Delisting from Euronext Amsterdam
|
|
Oct 10
|
BenevolentAI to Present on Explainable AI for Drug Discovery at BioTechX Europe 2024
|
|
Oct 7
|
BenevolentAI: using artificial intelligence to speed up drug discovery
|
|
Jun 25
|
BenevolentAI and AstraZeneca Collaboration Yields Continued Success as Further Novel Target Progressed Into Portfolio
|